Efficacy and safety of novel sodium glucose cotransporter-2 inhibitor remogliflozin in the management of type 2 diabetes mellitus: A systematic review and meta-analysis
2021 ◽
pp. 102315
2017 ◽
Vol 20
(1)
◽
pp. 113-120
◽
2016 ◽
Vol 18
(8)
◽
pp. 783-794
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 9
(3)
◽
2014 ◽
Vol 30
(4)
◽
pp. 269-283
◽
2019 ◽
Vol 8
(3)
◽
Keyword(s):